Advanced Prostate Cancer: Therapeutic Sequencing, Outcomes, and Cost Implications
February 7th 2013There is a dramatic revolution under way in the treatment of advanced-stage prostate cancer, which for many years consisted of systemic chemotherapy that offered only palliation of symptoms and no hope of improved survival.
HER2 Mutations Identified as Treatment Targets in Patients With HER2-Negative Breast Cancer
February 5th 2013Patients with breast cancer who do not exhibit amplifications of the HER2 gene may still have mutations of HER2 that drive the progression of their cancer, suggesting that these mutations could serve as therapeutic targets.
Potential Treatment Combinations for Melanoma Identified Through Novel Screening Approach
February 4th 2013A new drug screening method revealed that cholesterol-reducing statin drugs used in combination with cyclin-dependent kinase inhibitors might serve as an effective treatment approach for certain types of melanoma.
Study Suggests Patient Age Should Factor Into CLL Treatment Selection
January 30th 2013Research from the Ohio State University Comprehensive Cancer Center suggests that chlorambucil may be better than fludarabine in treating older patients with CLL, and that rituximab is beneficial regardless of age.